These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 16338164)
1. Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH). Kern P Parasitol Int; 2006; 55 Suppl():S273-82. PubMed ID: 16338164 [TBL] [Abstract][Full Text] [Related]
2. Status of the GCP guidelines in Europe. Geussenhainer S Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259 [TBL] [Abstract][Full Text] [Related]
4. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? Vuitton DA Expert Rev Anti Infect Ther; 2009 Mar; 7(2):145-9. PubMed ID: 19254162 [No Abstract] [Full Text] [Related]
6. The development of good clinical practice in the EEC and in Germany. Anhalt E Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258 [TBL] [Abstract][Full Text] [Related]
7. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives]. Englev E; Petersen KP Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823 [TBL] [Abstract][Full Text] [Related]
8. Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Davis A; Pawlowski ZS; Dixon H Bull World Health Organ; 1986; 64(3):383-8. PubMed ID: 3533299 [TBL] [Abstract][Full Text] [Related]
9. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097 [TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Bottomley A; Jones D; Claassens L Eur J Cancer; 2009 Feb; 45(3):347-53. PubMed ID: 19013787 [TBL] [Abstract][Full Text] [Related]
11. Establishing pan-European clinical trials: regulatory compliance and other practical considerations. Grienenberger A J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097 [TBL] [Abstract][Full Text] [Related]
12. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer]. Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963 [TBL] [Abstract][Full Text] [Related]
13. Stem cell transplantation in children: how to design a new study. Corbacioglu S; Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241 [TBL] [Abstract][Full Text] [Related]
14. [European guideline for the quality of non-commercial clinical trials: elegant implementation in the Netherlands via the amended Dutch Medical Research Involving Human Subjects Act]. Cohen AF Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1493-5. PubMed ID: 12924078 [TBL] [Abstract][Full Text] [Related]
15. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role]. Ainsworth MA Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819 [TBL] [Abstract][Full Text] [Related]